1. Home
  2. LMND vs MTSR Comparison

LMND vs MTSR Comparison

Compare LMND & MTSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMND
  • MTSR
  • Stock Information
  • Founded
  • LMND 2015
  • MTSR 2022
  • Country
  • LMND United States
  • MTSR United States
  • Employees
  • LMND N/A
  • MTSR N/A
  • Industry
  • LMND Property-Casualty Insurers
  • MTSR
  • Sector
  • LMND Finance
  • MTSR
  • Exchange
  • LMND Nasdaq
  • MTSR NYSE
  • Market Cap
  • LMND 2.8B
  • MTSR 3.0B
  • IPO Year
  • LMND 2020
  • MTSR 2025
  • Fundamental
  • Price
  • LMND $42.43
  • MTSR $28.98
  • Analyst Decision
  • LMND Hold
  • MTSR Strong Buy
  • Analyst Count
  • LMND 11
  • MTSR 6
  • Target Price
  • LMND $32.73
  • MTSR $55.25
  • AVG Volume (30 Days)
  • LMND 3.0M
  • MTSR 1.1M
  • Earning Date
  • LMND 07-29-2025
  • MTSR 08-26-2025
  • Dividend Yield
  • LMND N/A
  • MTSR N/A
  • EPS Growth
  • LMND N/A
  • MTSR N/A
  • EPS
  • LMND N/A
  • MTSR N/A
  • Revenue
  • LMND $558,600,000.00
  • MTSR N/A
  • Revenue This Year
  • LMND $29.15
  • MTSR N/A
  • Revenue Next Year
  • LMND $31.39
  • MTSR N/A
  • P/E Ratio
  • LMND N/A
  • MTSR N/A
  • Revenue Growth
  • LMND 23.12
  • MTSR N/A
  • 52 Week Low
  • LMND $14.90
  • MTSR $12.30
  • 52 Week High
  • LMND $53.85
  • MTSR $37.99
  • Technical
  • Relative Strength Index (RSI)
  • LMND 56.63
  • MTSR N/A
  • Support Level
  • LMND $41.80
  • MTSR N/A
  • Resistance Level
  • LMND $47.25
  • MTSR N/A
  • Average True Range (ATR)
  • LMND 2.93
  • MTSR 0.00
  • MACD
  • LMND -0.34
  • MTSR 0.00
  • Stochastic Oscillator
  • LMND 50.82
  • MTSR 0.00

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

Share on Social Networks: